Release Date: 10/03/20 09:54 Summary: Announcement under ASX Operating Rule 10A.4.3 Price Sensitive: No Download Document 398.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%